Ceftazidime-avibactam (CAZ-AVI), a novel antibiotic, is effective in treating infections caused by carbapenem-resistant Gram-negative bacteria. However, in patients receiving continuous renal replacem
The dataset used in the experiments is from an artificial liver dataset of a comprehensive tertiary hospital in Chengdu, containing clinical trial data of 206 patients. After excluding data features u
We analyzed 3651 non-PCOS patients, and the clinical characteristics of the two groups are shown in Supplemental Table 2 . There were statistically significant differences in BMI, gestational we
